Form 8-K - Current report:
SEC Accession No. 0001558370-25-006851
Filing Date
2025-05-08
Accepted
2025-05-08 07:15:40
Documents
49
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20250508x8k.htm   iXBRL 8-K 43071
2 EX-99.1 acrs-20250508xex99d1.htm EX-99.1 153620
3 EX-99.2 acrs-20250508xex99d2.htm EX-99.2 49228
4 GRAPHIC acrs-20250508xex99d1001.jpg GRAPHIC 5588
5 GRAPHIC acrs-20250508xex99d2g001.jpg GRAPHIC 134889
6 GRAPHIC acrs-20250508xex99d2g002.jpg GRAPHIC 340565
7 GRAPHIC acrs-20250508xex99d2g003.jpg GRAPHIC 236483
8 GRAPHIC acrs-20250508xex99d2g004.jpg GRAPHIC 116888
9 GRAPHIC acrs-20250508xex99d2g005.jpg GRAPHIC 93097
10 GRAPHIC acrs-20250508xex99d2g006.jpg GRAPHIC 86513
11 GRAPHIC acrs-20250508xex99d2g007.jpg GRAPHIC 163147
12 GRAPHIC acrs-20250508xex99d2g008.jpg GRAPHIC 78211
13 GRAPHIC acrs-20250508xex99d2g009.jpg GRAPHIC 127458
14 GRAPHIC acrs-20250508xex99d2g010.jpg GRAPHIC 140370
15 GRAPHIC acrs-20250508xex99d2g011.jpg GRAPHIC 134294
16 GRAPHIC acrs-20250508xex99d2g012.jpg GRAPHIC 130919
17 GRAPHIC acrs-20250508xex99d2g013.jpg GRAPHIC 82850
18 GRAPHIC acrs-20250508xex99d2g014.jpg GRAPHIC 128785
19 GRAPHIC acrs-20250508xex99d2g015.jpg GRAPHIC 143914
20 GRAPHIC acrs-20250508xex99d2g016.jpg GRAPHIC 113713
21 GRAPHIC acrs-20250508xex99d2g017.jpg GRAPHIC 123082
22 GRAPHIC acrs-20250508xex99d2g018.jpg GRAPHIC 93116
23 GRAPHIC acrs-20250508xex99d2g019.jpg GRAPHIC 83766
24 GRAPHIC acrs-20250508xex99d2g020.jpg GRAPHIC 129669
25 GRAPHIC acrs-20250508xex99d2g021.jpg GRAPHIC 112777
26 GRAPHIC acrs-20250508xex99d2g022.jpg GRAPHIC 49362
27 GRAPHIC acrs-20250508xex99d2g023.jpg GRAPHIC 94679
28 GRAPHIC acrs-20250508xex99d2g024.jpg GRAPHIC 130900
29 GRAPHIC acrs-20250508xex99d2g025.jpg GRAPHIC 146212
30 GRAPHIC acrs-20250508xex99d2g026.jpg GRAPHIC 116672
31 GRAPHIC acrs-20250508xex99d2g027.jpg GRAPHIC 136962
32 GRAPHIC acrs-20250508xex99d2g028.jpg GRAPHIC 102718
33 GRAPHIC acrs-20250508xex99d2g029.jpg GRAPHIC 126232
34 GRAPHIC acrs-20250508xex99d2g030.jpg GRAPHIC 73451
35 GRAPHIC acrs-20250508xex99d2g031.jpg GRAPHIC 148672
36 GRAPHIC acrs-20250508xex99d2g032.jpg GRAPHIC 148855
37 GRAPHIC acrs-20250508xex99d2g033.jpg GRAPHIC 134603
  Complete submission text file 0001558370-25-006851.txt   6169144

Data Files

Seq Description Document Type Size
38 EX-101.SCH acrs-20250508.xsd EX-101.SCH 3424
39 EX-101.LAB acrs-20250508_lab.xml EX-101.LAB 15917
40 EX-101.PRE acrs-20250508_pre.xml EX-101.PRE 10224
51 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20250508x8k_htm.xml XML 4792
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 25923843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)